Cogent Biosciences Stock (NASDAQ: COGT) stock price, news, charts, stock research, profile.
You can purchase shares of Cogent Biosciences (NASDAQ:COGT) through any online brokerage.
Other companies in Cogent Biosciences’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Replimune Group (NASDAQ:REPL) and Prothena Corp (NASDAQ:PRTA).
Cogent Biosciences has a consensus price target of $16.80.
The stock price for Cogent Biosciences (NASDAQ: COGT) is $8.1 last updated February 21, 2025 at 5:42 PM EST.
There are no upcoming dividends for Cogent Biosciences.
Cogent Biosciences’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Cogent Biosciences.
Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.